| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-17 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-06 |